Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies

被引:12
作者
Guillaume, Nicolas [1 ,2 ]
Marolleau, Jean-Pierre [2 ,3 ]
机构
[1] Ctr Hosp Univ, Lab Hematol & Histocompatibil, F-80054 Amiens 1, France
[2] Univ Picardie, EA Lymphocyte Normal Pathol & Canc 4666, Amiens, France
[3] Ctr Hosp Univ, Dept Hematol Clin & Therapie Cellulaire, F-80054 Amiens 1, France
关键词
Human leukocyte antigen; HLA; Chronic lymphocytic leukemia; Prognostic factor; Tumor immunogenicity; NATURAL-KILLER ACTIVITY; HLA-G EXPRESSION; DOWN-REGULATION; CELL-ACTIVITY; MECHANISM; NKG2D; DEFICIENCY; FREQUENT; LIGANDS; HLA-BW4;
D O I
10.1016/j.leukres.2012.12.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Changes in classical and non-classical human leukocyte antigen expression by tumor cells can play a critical role in the generation of tumor antigen-specific immune responses and can modulate the interactions of natural killer cells and T cell subpopulations with target cells. Recently, several studies have investigated the relations between HLA molecules and prognosis in B-CLL, suggesting a potential clinical relevance of tumor escape mechanisms. In this paper, we will summarize conflicting information about the role of HLA-related prognostic factors in B-CLL, such as downregulation of HLA class I antigen expression, interactions between natural killer cell receptor and certain ligands and the role of HLA-G expression. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:473 / 477
页数:5
相关论文
共 32 条
[1]  
ALVAREZMON M, 1987, EUR J HAEMATOL, V38, P268
[2]   HLA-G-dependent suppressor cells: Diverse by nature, function, and significance [J].
Carosella, Edgardo D. ;
HoWangYin, Kiave-Yune ;
Favier, Benoit ;
LeMaoult, Joel .
HUMAN IMMUNOLOGY, 2008, 69 (11) :700-707
[3]   Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia [J].
Costello, Regis T. ;
Knoblauch, Benjamin ;
Sanchez, Carole ;
Mercier, Delphine ;
Le Treut, Therese ;
Sebahoun, Gerard .
IMMUNOLOGY, 2012, 135 (02) :151-157
[4]   Prognostic factors in chronic lymphocytic leukemia-what do we need to know? [J].
Cramer, Paula ;
Hallek, Michael .
NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (01) :38-47
[5]   Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk [J].
Crowther-Swanepoel, Dalemari ;
Di Bernardo, Maria Chiara ;
Jamroziak, Krzysztof ;
Karabon, Lidia ;
Frydecka, Irena ;
Deaglio, Silvia ;
D'Arena, Giovanni ;
Rossi, Davide ;
Gaidano, Gianluca ;
Olver, Bianca ;
Lloyd, Amy ;
Broderick, Peter ;
Laurenti, Luca ;
Szemraj-Rogucka, Zofia ;
Robak, Tadeusz ;
Catovsky, Daniel ;
Houlston, Richard S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (02) :229-233
[6]   MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function [J].
Das, H ;
Groh, V ;
Kuijl, C ;
Sugita, M ;
Morita, CT ;
Spies, T ;
Bukowski, JF .
IMMUNITY, 2001, 15 (01) :83-93
[7]   Targeting HLA class I expression to increase tumor immunogenicity [J].
del Campo, A. B. ;
Carretero, J. ;
Aptsiauri, N. ;
Garrido, F. .
TISSUE ANTIGENS, 2012, 79 (03) :147-154
[8]   Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? [J].
Demanet, C ;
Mulder, A ;
Deneys, V ;
Worsham, MJ ;
Maes, P ;
Claas, FH ;
Ferrone, S .
BLOOD, 2004, 103 (08) :3122-3130
[9]   Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas [J].
Drénou, B ;
Tilanus, M ;
Semana, G ;
Alizadeh, M ;
Birebent, B ;
Grosset, JM ;
Dias, P ;
van Wichen, D ;
Arts, Y ;
De Santis, D ;
Fauchet, R ;
Amiot, L .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (01) :40-49
[10]   HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker? [J].
Erikci, Alev Akyol ;
Karagoz, Bulent ;
Ozyurt, Mustafa ;
Ozturk, Ahmet ;
Kilic, Selim ;
Bilgi, Oguz .
HEMATOLOGY, 2009, 14 (02) :101-105